AZATHIOPRINE SODIUM Drug Patent Profile
✉ Email this page to a colleague
When do Azathioprine Sodium patents expire, and what generic alternatives are available?
Azathioprine Sodium is a drug marketed by Hikma and is included in one NDA.
The generic ingredient in AZATHIOPRINE SODIUM is azathioprine sodium. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the azathioprine sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Azathioprine Sodium
A generic version of AZATHIOPRINE SODIUM was approved as azathioprine sodium by HIKMA on March 31st, 1995.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for AZATHIOPRINE SODIUM?
- What are the global sales for AZATHIOPRINE SODIUM?
- What is Average Wholesale Price for AZATHIOPRINE SODIUM?
Summary for AZATHIOPRINE SODIUM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 17 |
| Patent Applications: | 151 |
| DailyMed Link: | AZATHIOPRINE SODIUM at DailyMed |
Recent Clinical Trials for AZATHIOPRINE SODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Region Skane | PHASE4 |
| GlaxoSmithKline | PHASE4 |
| The University of Hong Kong | Phase 2 |
Pharmacology for AZATHIOPRINE SODIUM
| Drug Class | Purine Antimetabolite |
| Mechanism of Action | Nucleic Acid Synthesis Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for AZATHIOPRINE SODIUM
US Patents and Regulatory Information for AZATHIOPRINE SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | AZATHIOPRINE SODIUM | azathioprine sodium | INJECTABLE;INJECTION | 074419-001 | Mar 31, 1995 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
